Can unknown or permanent fillers be removed completely?

Removal of permanent and non-HA filler materials may be difficult, partial or sometimes impossible. A promise of 'one-session dissolution' is unreliable without product identity, tissue spread, scarring and complication assessment; surgery and other interventions also create new risks.

This translation has no recorded clinical or medical-language review.

Direct answer

Hyaluronidase does not dissolve every unknown or permanent material.
Complete removal may be impossible when product is integrated, dispersed or surrounded by scar tissue.
Benefit must be weighed against current symptoms, function, appearance and the risk of additional injury.

Why product identity is decisive

PMMA, silicone, calcium hydroxylapatite, poly-L-lactic acid and HA behave differently in tissue. Some may remain as particles or through biostimulatory effects. Remembering an old procedure only as 'filler' does not determine a removal option; labels, patient cards and practitioner records should be sought.

The role of imaging and sampling

Examination assesses location, firmness and inflammatory signs. Appropriate high-frequency ultrasound may help show some deposits and tissue relationships but does not identify every product with certainty. Laboratory testing, culture or pathology may be required when infection, granuloma or another condition is considered.

Limits of a removal decision

Surgical excision, drainage or other procedures carry risks of scarring, deformity, neurovascular injury and incomplete removal. Intervention for asymptomatic material is different from management of active infection or loss of function. The aim is not a total-removal slogan but safe management based on diagnosis and individual risk-benefit balance.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

Dermal Fillers (Soft Tissue Fillers)
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Guideline for the Management of Hyaluronic Acid Filler-Induced Vascular Occlusion
Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Safety and Potential Complications of Facial Wrinkle Correction with Dermal Fillers: A Systematic Literature Review
Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection
M. Alam et al. · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Factors Influencing Pre-Injection Aspiration for Hyaluronic Acid Fillers: A Systematic Literature Review and Meta-Analysis
D. J. Casabona · 2020
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review